← Back to all trials
Completed
NCT05043805
Dextromethorphan Added on for Children With Chronic Irritability
Conditions: Irritable Mood
Sex: All
Ages: 7 Years – 17 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 120
Sponsor: Tri-Service General Hospital (TSGH)
Location: Tri-Service General Hospital, National Defense Medical Center Taipei
Summary
Dextromethorphan Added on for Children With Chronic Irritability
Eligibility Criteria
Inclusion Criteria:
* Patients aged 7 to 17 who have irritability symptoms will be recruited. They will be screened for the irritability symptoms with ARI scale.
Exclusion Criteria:
* Patients who are not willing to participate in the study after detailed explanation.
* Patients who could not follow the investigator's instructions.
* Patients who have problems to express questions or emotional problems exactly.
* Patients who have severe neurological or mental illness like epileptic disorder, history of stroke, schizophrenia, bipolar disorder, mental retardation or uncontrolled suicide risk.
* Patients who have severe medical illness or surgical conditions like uncontrolled abnormal thyroid function, history of heart attack, uncontrolled hypertension.
* Patients who are allergic to methylphenidate or dextromethorphan.
* Patients with autoimmune disorders
* Patients with asthma or severe infection disorder currently or in the previous two months to avoid the influence of the level of cytokines.
Source: ClinicalTrials.gov (NCT05043805). StuddyBuddy aggregates publicly available trial information.